Disclosed herein is a process for chemically synthesizing of hydroquinone derivatives, especially for hydroquinone derivatives with heptadecatrienyl side chain, which is synthesized via a Wittig reaction of 2-(10-oxononyl)-1,4-diacetoxyl benzene and (3E, 5Z)-3,5-heptadien-1-triphenylphosphonium iodide and then deacetylation. In addition, the product is solid powder.

Disclosed herein is a process for chemically synthesizing of hydroquinone derivatives, especially for hydroquinone derivatives with heptadecatrienyl side chain, which is synthesized via a Wittig reaction of 2-(10-oxononyl)-1,4-diacetoxyl benzene and (3E, 5Z)-3,5-heptadien-1-triphenylphosphonium iodide and then deacetylation. In addition, the product is solid powder.

The present invention relates to the use of a compound of the general formula (I) wherein R.sup.1 is C.sub.1-C.sub.4-alkyl or (C=0)R.sup.3, R.sup.2 is hydrogen, C.sub.1-C.sub.4-alkyl or (C=0)R.sup.4, and R.sup.3 and R.sup.4, independently of one another, are selected from the group consisting of hydrogen and C.sub.1-C.sub.4-alkyl, a stereoisomer thereof or a mixture of stereoisomers thereof, as an aroma chemical, to aroma chemical compositions comprising at least one compound of the general formula (I), a stereoisomer thereof or a mixture of stereoisomers thereof, and to a method for preparing a fragranced ready-to-use composition, which comprises incorporating at least one compound of the general formula (I), a stereoisomer thereof or a mixture of stereoisomers thereof, into a ready-to-use composition. The present invention further relates to specific ethers and specific esters of the compounds of the general formula (I) and a method for their preparation.

##STR00001##

The present invention relates to the use of a compound of the general formula (I) wherein R.sup.1 is C.sub.1-C.sub.4-alkyl or (C=0)R.sup.3, R.sup.2 is hydrogen, C.sub.1-C.sub.4-alkyl or (C=0)R.sup.4, and R.sup.3 and R.sup.4, independently of one another, are selected from the group consisting of hydrogen and C.sub.1-C.sub.4-alkyl, a stereoisomer thereof or a mixture of stereoisomers thereof, as an aroma chemical, to aroma chemical compositions comprising at least one compound of the general formula (I), a stereoisomer thereof or a mixture of stereoisomers thereof, and to a method for preparing a fragranced ready-to-use composition, which comprises incorporating at least one compound of the general formula (I), a stereoisomer thereof or a mixture of stereoisomers thereof, into a ready-to-use composition. The present invention further relates to specific ethers and specific esters of the compounds of the general formula (I) and a method for their preparation.

##STR00001##

This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.

A compound of formula (I) wherein: M is selected from Mo or W; X is selected from O or NR.sup.5; R.sup.1 and R.sup.2 are independently selected from H, C.sub.1-6 alkyl, and aryl; C.sub.1-6 alkyl and aryl optionally being substituted with one or more of C.sub.1-6 alkyl, C.sub.1-6 alkoxy, and OC.sub.6H.sub.5; R.sup.3 is selected from a nitrogen-containing aromatic heterocycle being bound to M via said nitrogen; and from halogen; R.sup.4 is an aryl oxy group being bound to M via said oxygen of said aryl oxy group; wherein said aryl group Ar of said aryl oxy group is bound to a group Cat such to form a cationic ligand Cat.sup.+-ZArO, wherein Z is either a covalent bond or a linker; R.sup.5 is alkyl or aryl, optionally substituted.

##STR00001##

A compound of formula (I) wherein: M is selected from Mo or W; X is selected from O or NR.sup.5; R.sup.1 and R.sup.2 are independently selected from H, C.sub.1-6 alkyl, and aryl; C.sub.1-6 alkyl and aryl optionally being substituted with one or more of C.sub.1-6 alkyl, C.sub.1-6 alkoxy, and OC.sub.6H.sub.5; R.sup.3 is selected from a nitrogen-containing aromatic heterocycle being bound to M via said nitrogen; and from halogen; R.sup.4 is an aryl oxy group being bound to M via said oxygen of said aryl oxy group; wherein said aryl group Ar of said aryl oxy group is bound to a group Cat such to form a cationic ligand Cat.sup.+-ZArO, wherein Z is either a covalent bond or a linker; R.sup.5 is alkyl or aryl, optionally substituted.

##STR00001##

Embodiments in accordance with the present invention encompass compositions encompassing a latent organo-ruthenium compound and a pyridine compound along with one or more monomers which undergo ring open metathesis polymerization (ROMP) when said composition is exposed to suitable actinic radiation to form a substantially transparent film. Surprisingly, the compositions are very stable at ambient conditions to temperatures up to 80 C. for several days and undergo mass polymerization when subject only to actinic radiation. Accordingly, compositions of this invention are useful in various opto-electronic applications, including as 3D printing materials, coatings, encapsulants, fillers, leveling agents, among others.

Embodiments in accordance with the present invention encompass compositions encompassing a latent organo-ruthenium compound and a pyridine compound along with one or more monomers which undergo ring open metathesis polymerization (ROMP) when said composition is exposed to suitable actinic radiation to form a substantially transparent film. Surprisingly, the compositions are very stable at ambient conditions to temperatures up to 80 C. for several days and undergo mass polymerization when subject only to actinic radiation. Accordingly, compositions of this invention are useful in various opto-electronic applications, including as 3D printing materials, coatings, encapsulants, fillers, leveling agents, among others.

Disclosed are hydroquinone compounds, preparation methods therefor, and uses thereof in anti-tumor or immunomodulation. The structural formula of the hydroquinone compounds are shown by formula I,

##STR00001##

wherein X is CO or CH.sub.2; Y is NH, O or absent; R is: a substituted or unsubstituted alkyl group having at least one carbon atom, a substituted or unsubstituted cycloalkyl group having at least three carbon atoms, a substituted or unsubstituted alkenyl group or alkynyl group having at least two carbon atoms; and a substituted or unsubstituted aryl group or heteroaryl group containing at least four carbon atoms. The compounds provided slowly release 2-tert-butyl-4-methoxyphenol in vivo and maintain stable plasma concentration of 2-tert-butyl-4-methoxyphenol (T1/2=12-24 h). The compounds provided by the present invention protect the phenolic hydroxyl group of 2-tert-butyl-4-methoxyphenol, avoids environmental oxidation and increase the environmental stability of drugs containing the compounds.